Login / Signup

Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland.

Silvia StringhiniMaría-Eugenia ZaballaNick PullenCarlos de MestralJavier Perez-SaezRoxane DumontAttilio PicazioFrancesco PennacchioYaron DibnerSabine YerlyHelene BayssonNicolas VuilleumierJean-François BalavoineDelphine BachmannDidier TronoDidier PittetFrançois ChappuisOmar KheradLaurent KaiserAndrew S Azmannull nullIdris Guessous
Published in: Nature communications (2021)
Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK + study, a serosurvey of workers recruited after the first wave of the COVID-19 pandemic in Geneva, Switzerland. We tested workers (May 18-September 18, 2020) from 16 sectors and 32 occupations for anti-SARS-CoV-2 IgG antibodies. Of 10,513 participants, 1026 (9.8%) tested positive. The seropositivity rate ranged from 4.2% in the media sector to 14.3% in the nursing home sector. We found considerable within-sector variability: nursing home (0%-31.4%), homecare (3.9%-12.6%), healthcare (0%-23.5%), public administration (2.6%-24.6%), and public security (0%-16.7%). Seropositivity rates also varied across occupations, from 15.0% among kitchen staff and 14.4% among nurses, to 5.4% among domestic care workers and 2.8% among journalists. Our findings show that seropositivity rates varied widely across sectors, between facilities within sectors, and across occupations, reflecting a higher exposure in certain sectors and occupations.
Keyphrases
  • sars cov
  • healthcare
  • respiratory syndrome coronavirus
  • mental health
  • public health
  • palliative care
  • risk factors
  • big data
  • health information
  • artificial intelligence
  • chronic pain